Evidence map›Paper›PMID 42411169›Full record

ArticleJournal of gastric cancer2026

Real-World Evidence for Expanding the Criteria for Endoscopic Resection in Submucosal Gastric Cancer: The Role of Invasion Width.

Min-Jae Kim, Su-Jin Shin, In Gyu Kwon, Il Ju Choi, Keun Won Ryu, Yuna Kim, Jaeyoung Chun, Young Hoon Youn, Hyojin Park, Myeong-Cherl Kook and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of gastric cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Min-Jae KimDivision of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-6702-7692
Su-Jin ShinDepartment of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. charm@yuhs.ac.ORCID https://orcid.org/0000-0001-9114-8438
In Gyu KwonDepartment of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1489-467X
Il Ju ChoiCenter for Gastric Cancer, National Cancer Center, Goyang, Korea.ORCID https://orcid.org/0000-0002-8339-9824
Keun Won RyuCenter for Gastric Cancer, National Cancer Center, Goyang, Korea.ORCID https://orcid.org/0000-0002-5935-9777
Yuna KimDivision of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-1574-9121
Jaeyoung ChunDivision of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-4212-0380
Young Hoon YounDivision of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-0071-229X
Hyojin ParkDivision of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-4814-8330
Myeong-Cherl KookDepartment of Pathology, Center for Gastric Cancer, National Cancer Center, Goyang, Korea. mckook@ncc.re.kr.ORCID https://orcid.org/0000-0002-3435-3301
Jie-Hyun KimDivision of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. otilia94@yuhs.ac.ORCID https://orcid.org/0000-0002-9198-3326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe current expanded criteria for endoscopic resection (ER) of early gastric cancer (EGC) include a non-negligible risk of lymph node metastasis (LNM) in submucosal (SM) disease. We had previously proposed revised criteria incorporating the SM invasion width to better stratify LNM risk. In the present study, we aimed to validate whether these revised criteria improved the identification of truly node-negative, differentiated-type pT1b EGC. MATERIAL AND

methodsThis multicenter retrospective study included 712 patients with differentiated-type SM invasive EGC who underwent gastrectomy at 2 tertiary centers between 2016 and 2023. The SM invasion depth and width were re-evaluated, and the diagnostic performance of the conventional, expanded, and revised criteria (tumor size ≤3 cm, SM depth ≤1,000 µm, SM width ≤4 mm, and no lymphovascular/perineural invasion) for predicting LNM was compared.

resultsLNM was identified in 16.9% of the patients. An SM invasion width >4 mm was a strong independent predictor of LNM (P<0.001) and demonstrated superior discriminatory ability (area under the receiver operating characteristic curve [AUC], 0.79) in comparison with SM depth (AUC, 0.68) and tumor size (AUC, 0.59). Although the conventional criteria classified 54 cases as curative, the revised criteria classified 83 cases as curative, and no LNM events were observed in both sets of cases. Thus, the revised criteria expanded the potential candidate pool for curative ER by approximately 54% without compromising nodal safety.

conclusionsSM invasion width can be a significant independent predictor of LNM. The revised criteria, which incorporated SM width, safely expanded the indications for curative ER in patients with differentiated-type SM gastric cancer.

Indexed as

Endoscopic Mucosal ResectionGastrectomyStomach NeoplasmsAgedFemaleGastric MucosaHumansLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessRetrospective StudiesClinical pathologyEndoscopic submucosal dissectionGastrectomyGastric cancerLymph node metastasis

Identifiers

PMID42411169
PMCPMC13342265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.